Compare ADT Inc (ADT) vs Amphastar Pharmaceuticals Inc (AMPH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADT Inc vs Amphastar Pharmaceuticals Inc — how do they compare? ADT Inc trades at $7.46 (market cap $5.58B), while Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $863.95M). The key difference: ADT Inc is far larger — about 6.5× Amphastar Pharmaceuticals Inc's market cap, and ADT Inc pays a 2.88% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| ADT | AMPH | |
|---|---|---|
Market Cap | $5.58B | $863.95M |
Sector | Industrials | Health |
52-Week High | $8.85 | $30.81 |
52-Week Low | $6.30 | $16.87 |
Enterprise Value | $13.27B | $1.26B |
Dividend Yield | 2.88% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADT trades at $7.64, down 0.13% today, with a bullish technical signal from moving averages. The company reported Q2 2026 EPS of $0.23, beating estimates, and maintains strong profitability with an 11.86% net margin. Recent news highlights ADT's sponsorship of National Night Out 2026 and recognition as a top home security brand by Newsweek in May 2026.
Outlook is positive with consistent earnings beats and a 47% analyst buy rating, but risks include high debt levels and competitive pressures. The stock offers value with a P/E of 10.61 and dividend yield near 1.6%, supported by AI-driven growth initiatives.
AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.
Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADT Inc
ADT Inc is a provider of monitored security, interactive home and business automation, and related monitoring services in the United States and Canada. ADT offers residential, commercial, and multi-site customers a comprehensive set of burglary, video, access control, fire and smoke alarm, and medical alert solutions. It provides interactive home and business automation solutions designed to control access, react to movement, and sense carbon monoxide, flooding, changes in temperature or other environmental conditions, as well as address personal emergencies, such as injuries and medical emergencies. In addition, it offers professional monitoring of third-party devices through ADT Canopy platform. The product brands of the company are ADT and ADT Pulse, and Protection One brand.
Read more on ADT →About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →
